NCT03262441View on ClinicalTrials.gov

MMF for HIV Reservoir Reduction

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 12, 2018

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Human Immunodeficiency Virus I Infection
Interventions
DRUG

Mycophenolate Mofetil 500Mg Tab

500 mg once daily for one week. If tolerating the drug, then initiate twice daily for 22 months

Trial Locations (1)

98104

2 West Clinic at Harborview Medical Center, Seattle

All Listed Sponsors
collaborator

University of Washington

OTHER

lead

Fred Hutchinson Cancer Center

OTHER

NCT03262441 - MMF for HIV Reservoir Reduction | Biotech Hunter | Biotech Hunter